Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis-Reference-Cited by-同舟云学术

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis

Published:2014-03 Issue:3 Volume:133 Page:921-923
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Haldar Pranabashis,Brightling Christopher E.,Singapuri Amisha,Hargadon Beverley,Gupta Sumit,Monteiro William,Bradding Peter,Green Ruth H.,Wardlaw Andrew J.,Ortega Hector,Pavord Ian D.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference8 articles.

1. Mepolizumab and exacerbations of refractory eosinophilic asthma;Haldar;N Engl J Med,2009

2. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial;Pavord;Lancet,2012

3. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700;Kim;J Allergy Clin Immunol,2004

4. Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels;Stein;J Allergy Clin Immunol,2008

5. Changes in sputum eosinophils predict loss of asthma control;Jatakanon;Am J Respir Crit Care Med,2000

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The new biologic drugs: Which children with asthma should get what?;Pediatric Pulmonology;2024-09-13

2. Biomarkers and clinical outcomes after tezepelumab cessation;Annals of Allergy, Asthma & Immunology;2024-09

3. Stepping down biologics in asthma: is it time to challenge the status quo?;European Respiratory Journal;2024-08

4. Immunogenicity of biologics used in the treatment of asthma;Human Antibodies;2024-07-24

5. Titration of anti-IL-5 biologics in severe asthma: an open-label randomised controlled trial (the OPTIMAL study);European Respiratory Journal;2024-06-06